(Q408556)

has use

medication

0 references

chemical structure

Levobunolol.svg
512 × 201; 4 KB

0 references

mass

291.183 dalton

1 reference

LEVOBUNOLOL (English)

5-[(2R)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one

18 November 2016

stereoisomer of

2 references

inferred from InChI

chemical formula

C₁₇H₂₅NO₃

1 reference

LEVOBUNOLOL (English)

18 November 2016

canonical SMILES

CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O

1 reference

LEVOBUNOLOL (English)

18 November 2016

isomeric SMILES

CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CCCC2=O)O

1 reference

World Health Organisation international non-proprietary name

LEVOBUNOLOL (English)

18 November 2016

1 reference

14 February 2018

levobunolol (English)

1 reference

levobunolol (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

verapamil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fingolimod

1 reference

A reference set of clinically relevant adverse drug-drug interactions

verapamil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivastigmine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tamsulosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfuzosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methyldopa

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

terazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

doxazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

myocardial depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sinoatrial arrest

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxonidine

withdrawal hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fingolimod

atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

17 August 2016

1 reference

Adrenergic receptor, beta 3

17 August 2016

subject has role

antagonist

1 reference

17 August 2016

1 reference

InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1

17 August 2016

2 references

5 March 2018

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Levobunolol

0 references

Identifiers

InChI

1 reference

LEVOBUNOLOL (English)

18 November 2016

2 references

LEVOBUNOLOL (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

47141-42-4

2 references

levobunolol (English)

18 November 2016

https://commonchemistry.cas.org/detail?cas_rn=47141-42-4

9 April 2021

1 reference

Bunolol (English)

18 November 2016

2 references

LEVOBUNOLOL (English)

18 November 2016

Reaxys registry number

6484587

1 reference

levobunolol (English)

3 October 2016

ChEBI ID

6438

mapping relation type

2 references

LEVOBUNOLOL (English)

18 November 2016

International Chemical Identifier

InChI

InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1

1 reference

LEVOBUNOLOL (English)

18 November 2016

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

0 references

1 reference

Levobunolol (English)

publication date

17 November 2015

1 reference

D02.033.100.624.698.115.500

levobunolol (English)

18 November 2016

Levobunolol

0 references

MeSH concept ID

M0003033

0 references

MeSH tree code

0 references

D02.033.755.624.698.115.500

0 references

D02.092.063.624.698.115.500

0 references

D02.455.426.559.847.638.960.446.500

0 references

D04.615.638.960.446.500

0 references

RxNorm ID

1813

1 reference

levobunolol (English)

18 November 2016

DrugBank ID

DB01210

1 reference

Human Metabolome Database ID

HMDB0015341

2 references

2 references

levobunolol (English)

18 November 2016

MedlinePlus drug identifier

0 references

1 reference

levobunolol (English)

18 November 2016

0 references

1 reference

1 reference

levobunolol (English)

3 October 2016

1 reference

imported from Wikimedia project

levobunolol (English)

3 October 2016

0 references

1 reference

28 October 2013

Microsoft Academic ID

2777580761

0 references

Römpp online ID

RD-12-00993

1 reference

1 reference

levobunolol (English)

18 November 2016

C0080330

1 reference